• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多面肝素:抗凝治疗之外的多样应用

Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy.

作者信息

Sultana Razia, Kamihira Masamichi

机构信息

Department of Chemical Engineering, Faculty of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

Department of Biotechnology and Genetic Engineering, Faculty of Science, Noakhali Science and Technology University, Noakhali 3814, Bangladesh.

出版信息

Pharmaceuticals (Basel). 2024 Oct 12;17(10):1362. doi: 10.3390/ph17101362.

DOI:10.3390/ph17101362
PMID:39459002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11510354/
Abstract

Heparin, a naturally occurring polysaccharide, has fascinated researchers and clinicians for nearly a century due to its versatile biological properties and has been used for various therapeutic purposes. Discovered in the early 20th century, heparin has been a key therapeutic anticoagulant ever since, and its use is now implemented as a life-saving pharmacological intervention in the management of thrombotic disorders and beyond. In addition to its known anticoagulant properties, heparin has been found to exhibit anti-inflammatory, antiviral, and anti-tumorigenic activities, which may lead to its widespread use in the future as an essential drug against infectious diseases such as COVID-19 and in various medical treatments. Furthermore, recent advancements in nanotechnology, including nano-drug delivery systems and nanomaterials, have significantly enhanced the intrinsic biofunctionalities of heparin. These breakthroughs have paved the way for innovative applications in medicine and therapy, expanding the potential of heparin research. Therefore, this review aims to provide a creation profile of heparin, space for its utilities in therapeutic complications, and future characteristics such as bioengineering and nanotechnology. It also discusses the challenges and opportunities in realizing the full potential of heparin to improve patient outcomes and elevate therapeutic interventions.

摘要

肝素是一种天然存在的多糖,近一个世纪以来一直吸引着研究人员和临床医生,因其具有多种生物学特性,并已被用于各种治疗目的。肝素于20世纪初被发现,从那时起一直是一种关键的治疗性抗凝剂,目前其应用已成为治疗血栓性疾病及其他疾病的一种挽救生命的药理学干预措施。除了其已知的抗凝特性外,肝素还被发现具有抗炎、抗病毒和抗肿瘤活性,这可能使其在未来作为一种对抗COVID-19等传染病的基本药物以及在各种医学治疗中得到广泛应用。此外,包括纳米药物递送系统和纳米材料在内的纳米技术的最新进展,显著增强了肝素的内在生物功能。这些突破为医学和治疗中的创新应用铺平了道路,扩大了肝素研究的潜力。因此,本综述旨在提供肝素的创建概况、其在治疗并发症中的应用空间以及生物工程和纳米技术等未来特性。它还讨论了在充分发挥肝素潜力以改善患者预后和提升治疗干预措施方面所面临的挑战和机遇。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/11510354/ac6e47f94e60/pharmaceuticals-17-01362-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/11510354/29402d4fed0e/pharmaceuticals-17-01362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/11510354/c08124584591/pharmaceuticals-17-01362-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/11510354/f30a1a14c31e/pharmaceuticals-17-01362-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/11510354/de502c059c47/pharmaceuticals-17-01362-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/11510354/ac6e47f94e60/pharmaceuticals-17-01362-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/11510354/29402d4fed0e/pharmaceuticals-17-01362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/11510354/c08124584591/pharmaceuticals-17-01362-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/11510354/f30a1a14c31e/pharmaceuticals-17-01362-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/11510354/de502c059c47/pharmaceuticals-17-01362-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad9/11510354/ac6e47f94e60/pharmaceuticals-17-01362-g005.jpg

相似文献

1
Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy.多面肝素:抗凝治疗之外的多样应用
Pharmaceuticals (Basel). 2024 Oct 12;17(10):1362. doi: 10.3390/ph17101362.
2
Bioengineered heparin: Advances in production technology.生物工程肝素:生产技术的进步。
Biotechnol Adv. 2024 Dec;77:108456. doi: 10.1016/j.biotechadv.2024.108456. Epub 2024 Sep 24.
3
Diabetology and Nanotechnology: A Compelling Combination.糖尿病学与纳米技术:引人注目的结合。
Recent Pat Nanotechnol. 2025;19(1):4-16. doi: 10.2174/0118722105253055231016155618.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Pharmacological and clinical application of heparin progress: An essential drug for modern medicine.肝素的药理学和临床应用进展:现代医学的必备药物。
Biomed Pharmacother. 2021 Jul;139:111561. doi: 10.1016/j.biopha.2021.111561. Epub 2021 Apr 10.
6
Heparin: An old drug for new clinical applications.肝素:一种具有新临床应用的老药。
Carbohydr Polym. 2022 Nov 1;295:119818. doi: 10.1016/j.carbpol.2022.119818. Epub 2022 Jul 3.
7
Heparin: new life for an old drug.肝素:一种老药的新生命。
Nanomedicine (Lond). 2017 Jul;12(14):1727-1744. doi: 10.2217/nnm-2017-0127. Epub 2017 Jun 21.
8
A review on multifaceted biomedical applications of heparin nanocomposites: Progress and prospects.肝素纳米复合材料在多方面生物医学应用的综述:进展与展望。
Int J Biol Macromol. 2024 Mar;260(Pt 2):129379. doi: 10.1016/j.ijbiomac.2024.129379. Epub 2024 Jan 17.
9
Redefining Approaches to Asthma: Bridging the Gap Between Heparin and Its Anti-inflammatory Activities.重新定义哮喘治疗方法:弥合肝素与其抗炎活性之间的差距。
Curr Allergy Asthma Rep. 2017 Oct;17(10):70. doi: 10.1007/s11882-017-0738-6.
10
Research Progress on Antiviral Activity of Heparin.肝素的抗病毒活性研究进展。
Curr Med Chem. 2024;31(1):7-24. doi: 10.2174/0929867330666230203124032.

引用本文的文献

1
Epigenetic Biomarkers in Thrombophilia-Related Pregnancy Complications: Mechanisms, Diagnostic Potential, and Therapeutic Implications: A Narrative Review.血栓形成倾向相关妊娠并发症中的表观遗传生物标志物:机制、诊断潜力及治疗意义:一项叙述性综述
Int J Mol Sci. 2024 Dec 20;25(24):13634. doi: 10.3390/ijms252413634.

本文引用的文献

1
Bioengineered heparin: Advances in production technology.生物工程肝素:生产技术的进步。
Biotechnol Adv. 2024 Dec;77:108456. doi: 10.1016/j.biotechadv.2024.108456. Epub 2024 Sep 24.
2
Overview of the current procedures in synthesis of heparin saccharides.肝素糖合成的当前方法概述。
Carbohydr Polym. 2024 Sep 1;339:122220. doi: 10.1016/j.carbpol.2024.122220. Epub 2024 May 3.
3
Biosynthetic production of anticoagulant heparin polysaccharides through metabolic and sulfotransferases engineering strategies.通过代谢和磺基转移酶工程策略的生物合成生产抗凝肝素多糖。
Nat Commun. 2024 May 4;15(1):3755. doi: 10.1038/s41467-024-48193-5.
4
Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin.化学合成和生物学方法制备与猪源产品类似的生物工程肝素,并可转化为低分子量肝素。
Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2315586121. doi: 10.1073/pnas.2315586121. Epub 2024 Mar 18.
5
Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis.直接口服抗凝剂与低分子量肝素预防癌症手术后血栓形成的疗效和安全性:系统评价和荟萃分析。
World J Surg Oncol. 2024 Feb 26;22(1):69. doi: 10.1186/s12957-024-03341-5.
6
Distinct mechanisms underlying the therapeutic effects of low-molecular-weight heparin and chondroitin sulfate on Parkinson's disease.低分子量肝素和硫酸软骨素对帕金森病治疗作用的不同机制。
Int J Biol Macromol. 2024 Mar;262(Pt 1):129846. doi: 10.1016/j.ijbiomac.2024.129846. Epub 2024 Jan 29.
7
A review on multifaceted biomedical applications of heparin nanocomposites: Progress and prospects.肝素纳米复合材料在多方面生物医学应用的综述:进展与展望。
Int J Biol Macromol. 2024 Mar;260(Pt 2):129379. doi: 10.1016/j.ijbiomac.2024.129379. Epub 2024 Jan 17.
8
Polysaccharide-based hydrogels for medical devices, implants and tissue engineering: A review.用于医疗器械、植入物和组织工程的多糖基水凝胶:综述
Int J Biol Macromol. 2024 Jan;256(Pt 2):128488. doi: 10.1016/j.ijbiomac.2023.128488. Epub 2023 Dec 2.
9
Bivalirudin versus unfractionated heparin in patients with myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials.比伐卢定与普通肝素在经皮冠状动脉介入治疗的心肌梗死患者中的比较:系统评价和随机对照试验的荟萃分析。
Cardiovasc Revasc Med. 2024 Apr;61:52-61. doi: 10.1016/j.carrev.2023.10.014. Epub 2023 Oct 19.
10
Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.非ST段抬高型心肌梗死患者在经皮冠状动脉介入治疗期间使用比伐卢定与肝素的比较:大型随机试验的个体患者数据荟萃分析
Circulation. 2023 Oct 17;148(16):1207-1219. doi: 10.1161/CIRCULATIONAHA.123.063946. Epub 2023 Sep 25.